Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
A ALIMENTARY TRACT AND METABOLISM
A04 ANTIEMETICS AND ANTINAUSEANTS
A04A ANTIEMETICS AND ANTINAUSEANTS
A04AA Serotonin (5HT3) antagonists
A04AA55 Palonosetron, combinations
D10572 Fosnetupitant and palonosetron hydrochloride <US>
USP drug classification [BR:br08302]
Antiemetics
Emetogenic Therapy Adjuncts
Fosnetupitant/ Palonosetron
D10572 Fosnetupitant and palonosetron hydrochloride
Netupitant/ Palonosetron
D10572 Fosnetupitant and palonosetron hydrochloride
Drug groups [BR:br08330]
Metabolizing enzyme substrate
DG01642 CYP2C9 substrate
D10572 Fosnetupitant and palonosetron hydrochloride
DG01644 CYP2D6 substrate
D10572 Fosnetupitant and palonosetron hydrochloride
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
D10572 Fosnetupitant and palonosetron hydrochloride
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D10572
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D10572
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D10572
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D10572